BlackRock’s Nanobiotix NBTX Stock Holding History

BlackRock’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-51,484	Closed	-$148K	–	5487
2024 Q4	$148K	Sell	51,484 -177,435	-78%	-$710K	﹤0.01%	4682
2024 Q3	$1.32M	Sell	228,919 -10,089	-4%	-$52.6K	﹤0.01%	4117
2024 Q2	$1.2M	Sell	239,008 -14,446	-6%	-$87.1K	﹤0.01%	4132
2024 Q1	$1.65M	Buy	253,454 +34,939	+16%	+$247K	﹤0.01%	4067
2023 Q4	$1.59M	Buy	+218,515	New	+$1.38M	﹤0.01%	4117

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

BlackRock's NBTX Position: Q1 2025 in Review

BlackRock sold out of Nanobiotix (NBTX) in Q1 2025, closing a stake of 51,484 shares — an estimated $148K sold.

BlackRock first reported a position in NBTX in Q4 2023 and held it in 5 quarters. The position peaked at $1.65M in Q1 2024. 12 funds tracked by Wall St. Rank hold NBTX as of Q1 2025.

BlackRock reported no remaining Nanobiotix position as of Q1 2025 after selling out during the quarter.
BlackRock sold 51,484 Nanobiotix shares in Q1 2025, an estimated $148K.
BlackRock first reported a position in Nanobiotix in Q4 2023 and held it in 5 quarters.
BlackRock's Nanobiotix position peaked at $1.65M in Q1 2024.
12 funds tracked by Wall St. Rank held Nanobiotix as of Q1 2025.

Based on BlackRock's 13F filing for Q1 2025, filed 2 May 2025.